Commerzbank Aktiengesellschaft FI lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 84.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 440 shares of the medical equipment provider’s stock after selling 2,434 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in Intuitive Surgical were worth $460,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the stock. Skandinaviska Enskilda Banken AB publ boosted its holdings in Intuitive Surgical by 4.9% in the third quarter. Skandinaviska Enskilda Banken AB publ now owns 6,458 shares of the medical equipment provider’s stock valued at $2,251,000 after acquiring an additional 300 shares during the last quarter. KBC Group NV boosted its holdings in Intuitive Surgical by 9.5% in the third quarter. KBC Group NV now owns 5,818 shares of the medical equipment provider’s stock valued at $2,028,000 after acquiring an additional 504 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Intuitive Surgical by 0.4% in the third quarter. Dimensional Fund Advisors LP now owns 64,903 shares of the medical equipment provider’s stock valued at $67,869,000 after acquiring an additional 276 shares during the last quarter. MUFG Americas Holdings Corp acquired a new position in Intuitive Surgical in the third quarter valued at $208,000. Finally, Boston Private Wealth LLC boosted its holdings in Intuitive Surgical by 6.4% in the third quarter. Boston Private Wealth LLC now owns 2,276 shares of the medical equipment provider’s stock valued at $2,380,000 after acquiring an additional 136 shares during the last quarter. Hedge funds and other institutional investors own 32.81% of the company’s stock.

In other news, SVP Curet Myriam sold 262 shares of Intuitive Surgical stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $373.00, for a total transaction of $97,726.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Salvatore Brogna sold 6,082 shares of Intuitive Surgical stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $397.61, for a total value of $2,418,264.02. Following the sale, the chief operating officer now directly owns 3,096 shares in the company, valued at $1,231,000.56. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 55,944 shares of company stock worth $21,432,971. Corporate insiders own 2.20% of the company’s stock.

ISRG has been the topic of a number of recent research reports. Wedbush restated an “outperform” rating and set a $353.33 price objective on shares of Intuitive Surgical in a research note on Monday, September 25th. Barclays restated an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, October 20th. Morgan Stanley restated an “overweight” rating on shares of Intuitive Surgical in a research note on Tuesday, September 5th. Goldman Sachs Group restated a “buy” rating on shares of Intuitive Surgical in a research note on Saturday, November 18th. Finally, Vetr cut Intuitive Surgical from a “buy” rating to a “hold” rating and set a $111.83 price objective on the stock. in a research note on Wednesday, August 16th. Five investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $155.78.

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) opened at $379.61 on Monday. Intuitive Surgical, Inc. has a 52-week low of $206.27 and a 52-week high of $405.05. The stock has a market capitalization of $42,530.00, a PE ratio of 50.23, a PEG ratio of 5.27 and a beta of 0.48.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 19th. The medical equipment provider reported $2.77 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.99 by $0.78. Intuitive Surgical had a return on equity of 18.20% and a net margin of 30.16%. The business had revenue of $806.10 million for the quarter, compared to analyst estimates of $753.25 million. During the same period in the previous year, the company earned $2.06 earnings per share. The company’s revenue for the quarter was up 18.0% compared to the same quarter last year. analysts predict that Intuitive Surgical, Inc. will post 7.85 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another site, it was illegally copied and republished in violation of international trademark and copyright laws. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/12/11/intuitive-surgical-inc-isrg-stake-lowered-by-commerzbank-aktiengesellschaft-fi.html.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Stock Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related stocks with our FREE daily email newsletter.